دورية أكاديمية

Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus.

التفاصيل البيبلوغرافية
العنوان: Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus.
المؤلفون: Tedeschi SK; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA stedeschi1@bwh.harvard.edu., Johnson SR; Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Boumpas DT; Departments of Internal Medicine and Rheumatology, Clinical Immunology and Allergy, University of Crete, Heraklion, Greece., Daikh D; Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Department of Medicine, VA Medical Center, San Francisco, California, USA., Dörner T; Department of Medicine/Rheumatology and Clinical Immunology, Charite University Hospitals, Berlin, Germany., Diamond B; Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research, Manhasset, New York, USA., Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Center for Rheumatology and Spine Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jayne D; Department of Medicine, University of Cambridge, Cambridge, UK., Kamen DL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA., McCune WJ; Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA., Mosca M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Ramsey-Goldman R; Department of Medicine/Division of Rheumatology, Northwestern University, Chicago, Illinois, USA., Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Department of Internal Medicine, Biocruces Health Research Institute, Hospital Universitario Cruces, University of The Basque Country, Bizkaia, Spain., Schneider M; Rheumatology Department, University Hospital Dusseldorf, Dusseldorf, Germany., Urowitz M; Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada., Wofsy D; Department of Medicine, University of California San Francisco, San Francisco, California, USA., Smolen JS; Department of Rheumatology, Medical University of Vienna, Vienna, Austria., Naden RP; Department of Medicine, McMaster University, Hamilton, Canada., Aringer M; Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Dresden, Germany., Costenbader KH; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 May; Vol. 78 (5), pp. 634-640. Date of Electronic Publication: 2019 Jan 28.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: London : BMJ
Original Publication: London : H.K. Lewis
مواضيع طبية MeSH: Decision Support Techniques*, Lupus Erythematosus, Systemic/*classification , Rheumatology/*standards, Consensus ; Humans ; Reproducibility of Results ; Rheumatology/methods
مستخلص: European League Against Rheumatism and are jointly supporting multiphase development of systemic lupus erythematosus (SLE) classification criteria based on weighted criteria and a continuous probability scale. Prior steps included item generation, item reduction and hierarchical organisation of candidate criteria using an evidence-based approach. Our objectives were to determine relative weights using multicriteria decision analysis (MCDA) and to set a provisional threshold score for SLE classification. An SLE Expert Panel (8 European, 9 North American) submitted 164 real, unique cases with a wide range of SLE probability in a standardised format. Using the candidate criteria, experts scored and rank-ordered 20 representative cases. At an in-person meeting, experts reviewed inter-rater reliability of scoring, further refined criteria definitions and participated in an MCDA exercise. Based on expert consensus decisions on pairwise comparisons of criteria, 1000minds software calculated criteria weights and rank-ordered the remaining 144 cases based on their additive scores. The score of the lowest-ranked case for which complete expert consensus was achieved defined the provisional threshold classification score. Inter-rater reliability of scoring cases with the candidate criteria was good. MCDA involved 74 pairwise decisions and was repeated for the arthritis and mucocutaneous domains when the initial ranking of some cases did not match expert opinion. After criteria weights and additive scores were recalculated once, experts reached consensus for SLE classification for all cases scoring>83. Using an iterative process, the candidate criteria definitions were refined, preliminary weights were calculated and a provisional threshold score for SLE classification was determined.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
References: J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686)
Lupus. 2016 Jul;25(8):805-11. (PMID: 27252256)
Arthritis Care Res (Hoboken). 2018 Oct;70(10):1488-1494. (PMID: 29287313)
Ann Rheum Dis. 2019 May;78(5):634-640. (PMID: 30692164)
J Am Acad Dermatol. 2017 Aug;77(2):261-267. (PMID: 28606712)
Arthritis Rheum. 2012 Aug;64(8):2677-86. (PMID: 22553077)
Arthritis Rheum. 2010 Sep;62(9):2582-91. (PMID: 20872596)
Arthritis Rheum. 2010 Sep;62(9):2569-81. (PMID: 20872595)
J Clin Epidemiol. 2014 Jun;67(6):706-14. (PMID: 24721558)
Arthritis Rheum. 2007 Oct 15;57(7):1119-33. (PMID: 17907227)
Kidney Int. 2004 Feb;65(2):521-30. (PMID: 14717922)
J Rheumatol. 2019 Jul;46(7):721-726. (PMID: 30554156)
Semin Arthritis Rheum. 2011 Oct;41(2):95-105. (PMID: 21420149)
Arthritis Rheum. 2013 Nov;65(11):2737-47. (PMID: 24122180)
Arthritis Rheum. 2006 Jun 15;55(3):348-52. (PMID: 16739201)
Arthritis Rheumatol. 2015 Oct;67(10):2557-68. (PMID: 26352873)
Arthritis Rheum. 1982 Nov;25(11):1271-7. (PMID: 7138600)
Ann Rheum Dis. 2017 Jan;76(1):9-16. (PMID: 27789466)
Lupus. 2018 Aug;27(9):1431-1436. (PMID: 29771193)
Arthritis Rheum. 2007 Jan;56(1):265-73. (PMID: 17195230)
Arthritis Care Res (Hoboken). 2018 Apr;70(4):571-581. (PMID: 28692774)
Arthritis Rheumatol. 2019 Jan;71(1):91-98. (PMID: 30035365)
Arthritis Care Res (Hoboken). 2018 Mar;70(3):428-438. (PMID: 28544593)
معلومات مُعتمدة: K24 AR066109 United States AR NIAMS NIH HHS; L30 AR070514 United States AR NIAMS NIH HHS
فهرسة مساهمة: Keywords: clinical research; methodology; systemic lupus erythematosus
تواريخ الأحداث: Date Created: 20190130 Date Completed: 20191230 Latest Revision: 20231113
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7057251
DOI: 10.1136/annrheumdis-2018-214685
PMID: 30692164
قاعدة البيانات: MEDLINE
الوصف
تدمد:1468-2060
DOI:10.1136/annrheumdis-2018-214685